Link to original story in San Diego Tribune
Read more at website ClinicalTrials.gov
|
Neurotoxicants.com, website of Dr. Marcia Ratner, expert, neurotoxicologist consulting in neurotoxicology, neurotoxins, neurotoxicants, and neurodegenerative disease |
|
The Australian government has approved a first of its kind clinical trial of stem cell therapy for Parkinson's disease. The study conducted by International Stem Cell Corporation's Australian subsidiary, Cyto Therapeutics, will recruit 12 patients who will be treated with neural precursor cells derived from parthenogenetic stem cells, which are produced from unfertilized human eggs, and act like embryonic stem cells.
Link to original story in San Diego Tribune Read more at website ClinicalTrials.gov
0 Comments
Your comment will be posted after it is approved.
Leave a Reply. |
AuthorDr. Marcia Ratner shares and reviews the news. Archives
February 2023
Categories |